Published ahead of print on June 18, 2009 Am. J. Respir. Cell Mol. Biol. 2009, doi:10.1165/rcmb.2009-0123OC
Submitted on April 8, 2009 MicroRNA Expression in Human Airway Smooth Muscle Cells: Role of miR-25 in Regulation of Airway Smooth Muscle PhenotypeAndrew R Kuhn1,1 Pharmacology, University of Nevada School of Medicine, Reno, Nevada, United States, 2 Biochemistry, UNR Bioinformatics Core, University of Nevada School of Medicine, Reno, Nevada, United States, 3 Physiology and Section of Respiratory Diseases, University of Manitoba, Winnepeg, Canada, 4 Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, United States, 5 Pharmacology, University of Nevada School of Medicine, MS318, Reno, 89523, United States * To whom correspondence should be addressed. E-mail: csinger{at}medicine.nevada.edu.
Mechanisms by which differentiated, contractile smooth muscle cells become proliferative and secretory is one way airway smooth muscle (ASM) cells respond to mechanical and environmental stress and contributes to inflammatory responses in the lung that result in airway disease. Regulation by microRNAs (miRNAs) has emerged as an important post-transcriptional mechanism regulating gene expression that may modulate ASM phenotype but little is known about the expression and functions of miRNA in smooth muscle. In the present studies, we use microarrays to determine if miRNAs in human ASM cells are altered by a pro-inflammatory stimulus. In ASM cells exposed to IL-1 Key words: smooth muscle gene expression miRNA inflammation remodeling
|
|